JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2015, Vol. 29 ›› Issue (5): 47-49.doi: 10.6040/j.issn.1673-3770.0.2015.150

Previous Articles     Next Articles

The relationship between D-Dimer and nasopharyngeal carcinoma

CHE Juan1, ZHAO Hongchun1, LI Jinling2, WANG Yanfei1   

  1. 1. Department of Otolaryngology, the Affiliated Hospital of Binzhou Medical University, Binzhou 256603, Shandong, China;
    2. Department of Laboratory Medicine, the Affiliated Hospital of Binzhou Medical University, Binzhou 256603, Shandong, China
  • Received:2015-04-09 Revised:2015-07-09 Online:2015-10-16 Published:2015-10-16

PDF (PC)

874

Abstract: Objective To investigate the prognostic value of plasma D-dimer for nasopharyngeal carcinoma. Method Sixty-nine nasopharyngeal carcinoma patients and their gender-and age-matched healthy individuals were prospectively enrolled, and their plasma D-Dimer on admission were compared. The association between plasma D-Dimer and clinical stage of nasopharyngeal carcinoma was analyzed. The prognostic value of D-dimer for all-cause mortality was estimated by receiver operating characteristic (ROC) curves and Kaplan-Meier approach. Results Compared with healthy individuals, nasopharyngeal patients had significantly higher plasma D-dimer. Plasma D-Dimer increased as the advance of clinical stage of nasopharyngeal carcinoma. The area under ROC curve of plasma D-Dimer for all-cause mortality was 0.72. Patients with increased D-Dimer (more than 0.55 mg/L) have higher risk of death than the patients with normal D-Dimer (less than 0.55 mg/L). Conclusion D-Dimer is a useful prognostic factor for nasopharyngeal carcinoma. Increased D-Dimer is associated with poor prognosis.

Key words: D-Dimer, Prognosis, Nasopharyngeal carcinoma

CLC Number: 

  • R766.3
[1] 邹丽芳, 朱琦, 程毅敏, 等. 血液系统恶性肿瘤患者止凝血功能的研究[J]. 血栓与止血学, 2013, 19(6):257-260. ZOU Lifang, ZHU Qi, CHENG Yimin, et al. The study of heamostatic function in patients with hematological malignancy[J]. Chin J Thrombosis Hemostasis, 2013, 19(6):257-260.
[2] 许小毛, 王辰. 肿瘤与静脉血栓栓塞症[J]. 中国实用内科杂志, 2013, 33(5):344-347. XU Xiaomao, WANG Chen. Cancer and venous thromboembolism[J]. Chin J Prac Inter Med, 2013, 33(5):344-347.
[3] Olson J D, Cunningham M T, Higgins R A, et al. D-dimer: simple test, tough problems[J]. Arch Pathol Lab Med, 2013, 137(8):1030-1038.
[4] Tripodi A. D-dimer testing in laboratory practice[J]. Clin Chem, 2011, 57(9):1256-1262.
[5] Zhou Y X, Yang Z M, Feng J, et al. High plasma D-dimer level is associated with decreased survival in patients with lung cancer: a meta-analysis[J]. Tumour Biol, 2013, 34(6):3701-3704.
[6] Liu L, Zhang X, Yan B, et al. Elevated plasma d-dimer levels correlate with long term survival of gastric cancer patients[J]. PLoS One, 2014, 9(3):e90547.
[7] 张弘, 刘陶文, 莫碧媛, 等. 鼻咽癌患者血浆D-二聚体水平测定的临床价值[J]. 华夏医学, 2009, 22(1):55-56. ZHANG Hong, LIU Taowen, MO Biyuan, et al. Clinical value of D-Dimer in nasopharyngeal carcinoma[J]. Acta Med Sinica, 2009, 22(1):55-56.
[8] 胡志德, 王璐璐, 赫慧楠. 5种恶性肿瘤患者血浆D二聚体阳性检出率比较[J]. 血栓与止血学, 2006, 12(6):2. HU Zhide, WANG Lulu, HE Huinan. The positive rate of plasma d-dimer in five type patients with malignant tumor[J]. Chin J Thrombosis Hemostasis, 2006, 12(6):2.
[9] Coussens L M, Werb Z. Inflammation and cancer[J]. Nature, 2002, 420(6917):860-867.
[10] Cugno M. Inflammation, coagulation, vascular permeability and thrombosis[J]. Curr Vasc Pharmacol, 2012, 10(5):631.
[1] LIN Xiaoxue, LIN Baorui, LI Peishan, LU Biaoqing. Application of electronic nasopharyngoscopy combined with narrow band imaging in traditional Chinese medicine syndrome differentiation of nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(3): 40-46.
[2] MIAO Hongli, ZHANG Yanchun, HAO Linna, TANG Le, HE Yingnan. Clinical features and prognostic analysis of active ocular toxoplasmosis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 82-89.
[3] PENG Zhonghua, CHEN Zhu, YUAN Luohua, YU Shaolan, MA Yuling. Primary high-grade non-intestinal-type adenocarcinoma of the nasal cavity: a case report and review of the literature [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 95-98.
[4] LI Zan, LU Qi, SHEN Weidong, HOU Zhaohui, WU Nan. Clinical diagnosis and treatment features of 18 cases of necrotizing otitis externa [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 17-22.
[5] LIU Yuzhu, CHEN Yao, YUAN Tiejun, LI Chunsen, LI Bo. Larynx fibrosarcoma: a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 133-137.
[6] WANG Sheng, LI Yindan, YANG Jinji. The role of microRNA in nasopharyngeal carcinoma and its research progress [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 125-131.
[7] QIU Qianhui, XIAO Xuping, YANG Qintai, YE Jing, DENG Zeyi, WANG Desheng, TAN Guolin, JIANG weihong,. Expert consensus on clinical management recommendations for carotid blowout syndrome secondary to NPC treatment [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 1-18.
[8] WANG Siquan, ZHU Hongshen, ZHANG Xiaobin, ZHAO Zhouyang, MA Yue, YANG Yimei, HUANG Lijin. Analysis of factors associated with stroke and cranial nerve palsy after unilateral internal carotid artery embolization in patients with nasopharyngeal carcinoma after radiotherapy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 19-25.
[9] HUANG Qiao, REN Yi, HOU Tao, LIAO Xingwei, ZHU Zi’ang, ZHAN Xiaolin, LIU Ying, YIN Shihua. Expression of EphB2 in nasopharyngeal carcinoma tissues and its correlation with clinicopathological characteristics [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 26-30.
[10] SUN Chunxiao, WANG Wenqing, YUE Tian, LIU Jisheng. Efficacy analysis of concurrent chemoradiotherapy with high and low cumulative cisplatin doses in the treatment of nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 31-41.
[11] WANG Zaixing, TANG Zhiyuan, LI Dingbo, SHI Zhaohui, ZENG Xianhai, ZHANG Qiuhang. Treatment of internal carotid artery rupture caused by tumor recurrence and skull base osteonecrosis after radiotherapy for nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 49-58.
[12] SUN Fang, XIE Chubo, QIU Qianhui. Retrospective analysis of nutritional indexes and their impact on wound healing in patients with radiation-induced skull base osteoradionecrosis after treatment with nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 59-68.
[13] ZHU Ruikai, WU Jiarong, SUN Fang, XIE Chubo, QIU Qianhui. Computed tomography angiography-based assessment of internal carotid artery stenosis after radiotherapy for nasopharyngeal carcinoma and its associated factors [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 77-84.
[14] QIN Debo, XUE Jiancheng, YANG Wenyue, HU Bing, CHEN Tao, YU Yanping, MENG Qingguo, SUN Huanji, MIAO Beiping, LU Yongtian. Changing the diagnosis and treatment of nasopharyngeal cancer: biomarkers and nasal endoscopic surgery synergise to advance early treatment development [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 85-92.
[15] WU Jiarong, QIU Qianhui. The role and significance of the skull base fascial tissue barrier in endoscopic resection of locally early recurrent nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 108-113.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd